quantitative
Analysis v1
Strong Support
If HIV patients keep taking tesamorelin for a full year, their dangerous belly fat drops by about 18% compared to when they started — but we don’t know how much better that is than just stopping the drug, because the placebo group didn’t stay on it for a year.
81
0
Evidence from Studies
Supporting (1)
81
Community contributions welcome
81
The study found that HIV patients who took tesamorelin daily for a year lost about 18% of their dangerous belly fat, and when they stopped taking it, the fat came back — so the drug caused the loss, not just time or luck.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found